RECENT SUCCESSFUL RESEARCH AWARDS:
Published: 3 March 2020
Current successful awards within our school
Professor Colin Berry. 'Angina after PCI: a systems approach to inform downstream strategies', British Heart Foundation, £1,081,035
Professor Colin Berry. 'National Leader for the MK-0616 Phase 3 Program', Merck (UK), £177,000
Dr John Mercer. 'Development of an implantable vascular electroporator', Philips (Philips Healthcare) (US), £493,219.37
Dr John Mercer. 'VascuGraft: A self-reporting diagnstic and therapeutic implant technology for Chronic Kidney Disease', Scottish Enterprise, £74,875.21
Dr John Mercer. 'iCure Discovery Programme', Innovate UK, £2,500
Dr Rachel Myles. 'SCOTland CardiomyopatHy Registry (Bio-SCOTCH)', Roche (CH), £475,909.04
Professor Godfrey Smith. 'Chronic myocardial infarction in rabbits to evaluate next generation therapeutics', British Heart Foundation (BHF), £156,202.97
Dr Jennifer Burton. 'Dunhill Medical Trust Academy Excellence Award - Rising Star', Dunhill Medical Trust, £120,000
Professor Patrick Mark. 'Pragmatic randomised study of High Or Standard PHosphAte Targets in End-stage kidney disease - The PHOSPHATE Study', National Institute for Health Research (NIHR), £92,955.34
Professor Terry Quinn. 'Research Fellowship', Royal College of Physcians and Surgeons of Glasgow (RCPSG), £76,376.62
Professor Terry Quinn. 'Research Fellowship', The Vascular Society, £74,836.87
Professor Terry Quinn. 'Antidepressants for Emotionalism After StrokE (EASE)', National Institute for Health Research (NIHR), £40,984.88
Professor Naveed Sattar, 'Ziltivekimab CVOT StC', Novo Nordisk (DK), £64,260
Professor Jesse Dawson, 'Micro transponder's Vivistim System - J Dawson GC15NE049', MicroTransponder Inc, £59,977
Professor Jesse Dawson, 'A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, for Stroke Prevention after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack', Janssen (BE), £31,446
Professor Jesse Dawson, 'Andexanet alfa development program (CR-028801)', AstraZeneca AB (SE), £10,500
Professor Jesse Dawson, 'A Global, Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of BMS-986177...to Optimize Management of Acute Thromboembolic events in Secondary Stroke Prevention', Bristol-Myers Squibb (BMS) (US), £5,405
Professor John McMurray, 'Provide support to the BC007 study.', Berlin Cures GmbH, £59,500
Professor John McMurray, 'External expert for baxdro/dapa HF Ph3 planning, design and study conduct including', AstraZeneca (US), £35,000
Professor John McMurray, 'Member of the Executive Committee for the Forxiga HFpEF study (D169CC00005)', AstraZeneca (UK), £15,000
Professor John McMurray, 'Consultancy activities related to the DAPA Thought Leaders Scientific Exchange Meeting', AstraZeneca (UK), £5,100
Professor John McMurray, 'Consultancy for Renal services', Bayer (BE), £4,500
Professor John McMurray, 'focus on target patient population, treatment goals, and clinical endpoints in non-ischemic HFrEF.', Bayer (DE), £3,000
Professor John McMurray, 'The next step of SGLT2i ¿ Clinical implication on HF Management - July 11th, Campinas', AstraZenceca Brasil Ltda, £2,850
Professor John McMurray, 'Participate in the REGENERON NPR1 ADVISORY BOARD MEETING', Regeneron Pharmaceuticals Inc, £909
Dr Connor Blair, 'Development of a next-generation MDM2 inhibitor against high-risk TP53 mutant Neuroblastoma’, Medical Research Council, £42,500
Professor John Cleland, 'Transforming heart failure care', Innovate UK, £19,153
Professor John Cleland, 'Various consultancy activities', Edward Lifesciences SA, £9,554
Professor John Cleland, 'Cardiac surgery advisory board', Pharmacosmos UK Ltd, £5,340
Professor John Cleland, 'Swedish Society of Cardiology Symposium', Pharmacosmos UK Ltd, £3,029
Professor Jason Gill, 'Leveraging Malawian cohorts and biobank to establish sustainable community responses aimed at addressing cardiometabolic risk in both rural and urban settings', National Institute for Health Research (NIHR), £10,000
Dr Richard Good, 'Quantification of heart artery calcification in contrast enhanced, non-cardiac CT scans: a comparison with the Agatston score derived from dedicated cardiac CT imaging.', Scottish Funding Council (SFC), £6,955
Dr Josie Fullerton, 'Neurophysiology of preclinical menopause', Alzheimer`s Research UK Scotland Network Centre, £2,980
First published: 3 March 2020
<< News